Ligand profile
NKI
Ligand co-crystallized with a similar protein (Protein Data Bank).
Bound to: VK055_3566 — ankyrin repeat family protein
Identifiers
Database identifiers and provenance.
- Ligand ID
NKI- PDB
5akw- UniProt (similar protein)
Q9H2K2- Target protein
- VK055_3566
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 41.1
- −1 ≤ LogP ≤ 5 3.19
- MW ≤ 500 Da 258.7
- LogP ≤ 5 3.19
- H-bond donors ≤ 5 2
- H-bond acceptors ≤ 10 2
- Rotatable bonds ≤ 10 1
- TPSA ≤ 140 Ų 41.1
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
c1ccc2c(c1)C(=O)N[C@H](N2)c3ccc(cc3)Clc1ccc2c(c1)C(=O)N[C@H](N2)c3ccc(cc3)Cl
InChI=1S/C14H11ClN2O/c15-10-7-5-9(6-8-10)13-16-12-4-2-1-3-11(12)14(18)17-13/h1-8,13,16H,(H,17,18)/t13-/m0/s1InChI=1S/C14H11ClN2O/c15-10-7-5-9(6-8-10)13-16-12-4-2-1-3-11(12)14(18)17-13/h1-8,13,16H,(H,17,18)/t13-/m0/s1
FPWIEUZTQYJRJZ-ZDUSSCGKSA-NFPWIEUZTQYJRJZ-ZDUSSCGKSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Source
- PDB
- Binding sites
- PF00644
External resources
Open this ligand in third-party databases and cheminformatics tools.
- PDB RCSB ligand NKI →
- PDB RCSB structure 5akw →
- UniProt UniProt Q9H2K2 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “NKI”) →
Other ligands for this protein
Quick navigation to other ligands bound to VK055_3566.
PDB 124
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 100
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 50
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).